Lau, Paul, et al. “NMP22 Is Predictive of Recurrence in High-Risk Superficial Bladder Cancer Patients”. Canadian Urological Association Journal, vol. 3, no. 6, May 2013, pp. 454-8, doi:10.5489/cuaj.1173.